MentionFox
Home › funding signals › AdhereBio LLC
Form D · on the record

AdhereBio LLC — Form D filing, October 2026

AdhereBio LLC filed a Form D with the Securities and Exchange Commission on 2026-10-26.

AdhereBio LLC filed a Form D notice of an exempt securities offering with the SEC on October 26, 2026. Its industry group is Biotechnology. It names Shawn Barrieau (Executive Officer) (SEC Form D, October 26, 2026).

2 more Biotechnology raises in Florida, October 2026 ↓

Selling to AdhereBio LLC? See who runs it and how to reach them, plus this week's 44 other newly funded companies.

Is this your company?

Key facts

Run the free check on AdhereBio LLC →

Sell to companies like AdhereBio LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

AdhereBio LLC

New Form D on file · 2026-10-26 · the record

$0
raise on the record
D
filing
0
investors in
FLORIDA
based
Open the record →

What the record says

FilingForm D
Filed2026-10-26
Industry groupBiotechnology
Entity typeLimited Liability Company
Incorporated inDELAWARE
Year formed2026
BasedFORT LAUDERDALE, FLORIDA
CIK2160633
Accession0002134718-26-000101

Pitching, partnering or investing alongside them? See who really runs and owns AdhereBio LLC.

Free to see. No signup.

Keep reading

More on the people and the money behind AdhereBio LLC, from the filings we hold.

More raises like this

Biotechnology raises by companies based in Florida, filed in October 2026, largest first.

What do you want to do with AdhereBio LLC?

Get the full cited report on AdhereBio LLC

What the filing shows about AdhereBio LLC

  • The filing reports $100K of the proceeds going to the company's own executives, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on AdhereBio LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives AdhereBio LLC's address as 215 N New River Dr E Ste 2820, Fort Lauderdale, FL 33301.

What the filing says

  • Offered: $5,000,000. Sold: nothing yet. Left to sell: $5,000,000. (filing)
  • Investors: 0 had already invested. (filing)
  • Date of first sale: yet to occur. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $100,000 of the proceeds is used or proposed to be used for such payments (the filing marks this amount as an estimate). The filing explains: “An initial payment of $100,000 from the proceeds will go to SK Laboratories to satisfy initial license on patented technology that AdhereBio is using to sell in the market.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on AdhereBio LLC See pricing

Is AdhereBio LLC a real, registered company?

AdhereBio LLC is a registered filer with the SEC (CIK 2160633) and has filed since 2026-10-26. 1 filing is on record, the latest on 2026-10-26.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs AdhereBio LLC?

AdhereBio LLC's Form D of 2026-10-26 names Shawn Barrieau as its officers, directors or promoters.

Biotechnology · by week

Trailing twelve months. 759 filings in Biotechnology, totalled by week.

Want the whole picture on AdhereBio LLC?

What the filing shows about AdhereBio LLC

  • The filing reports $100K of the proceeds going to the company's own executives, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on AdhereBio LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on AdhereBio LLC covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind AdhereBio LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for AdhereBio LLC. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/adherebio-llc-form-d-000101
Last updated 2026-10-27
Primary record: SEC filing 1 · SEC filing 2
AdhereBio LLC — SEC Form D filing, October 2026. MentionFox, 2026-10-27. https://mentionfox.com/funding/adherebio-llc-form-d-000101